Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
about
The Non-structural Protein 5 and Matrix Protein Are Antigenic Targets of T Cell Immunity to Genotype 1 Porcine Reproductive and Respiratory Syndrome Viruses.Recognition of Highly Diverse Type-1 and -2 Porcine Reproductive and Respiratory Syndrome Viruses (PRRSVs) by T-Lymphocytes Induced in Pigs after Experimental Infection with a Type-2 PRRSV Strain.Rescue and evaluation of a recombinant PRRSV expressing porcine Interleukin-4.Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus.Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus.Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.Molecular epidemiology of porcine reproductive and respiratory syndrome viruses isolated from 1991 to 2013 in Taiwan.Comparison of commercial type 1 and type 2 PRRSV vaccines against heterologous dual challenge.Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)-Modified Live Vaccines Reduce Seminal Shedding of Type 1 PRRSV but not Type 2 PRRSV in Infected Boars.Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus, Mycoplasma hyopneumoniae, and porcine circovirus type 2 on a 3 pathogen challenge model.Multi-resistance strategy for viral diseases and in vitro shRNA verification method in pigs.Coinfection with type 1 and type 2 PRRSV.Recent advances in veterinary applications of structural vaccinology.Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain.Pigs that recover from porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4+CD8+ and CD4+CD8- T-cells that kill virus infected cells
P2860
Q35933545-F276A630-DCBE-464E-906B-9F92D517B0E9Q36178539-3B44B944-EB9F-4F4D-B329-79444AE7C9E4Q36286076-042D6FEF-FC83-40CD-A44C-51155219022EQ36390103-9017358A-4862-40C8-A4C5-8318E0A78297Q37572027-BC848E1F-3041-46C5-A3A7-0F21158B3CF2Q38939617-6826D4D4-2215-4071-BA11-228C9C801043Q40556828-FAE0C7D3-F9BC-4012-9E1D-57735F713462Q40656239-94027A8D-7206-4C64-AB9D-9711D81A94F7Q40796769-0F1B52B6-4CDE-4409-8813-8724ABD84C2CQ41328738-A53D785F-3CD2-49EB-B69C-0998B5384C73Q47547768-91C1BAC4-A89A-4F2C-B057-9C91B68293A6Q47561744-FD391D63-1501-40BE-BBB5-664A5F71333DQ50881356-2077B39E-FAC4-41AA-A2A9-4DF165090A9FQ52650429-0F6A8F74-C41E-439C-B913-4F1E651FDB8CQ55018531-0C0A6A1C-2AE8-4978-B82C-DE977ECE62A9Q57160272-DCE8FAE1-42C4-4BC4-BAF9-89DDD46C0F58
P2860
Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Evaluation of the efficacy of ...... heterologous PRRSV challenge.
@en
Evaluation of the efficacy of ...... and respiratory syndrome virus
@nl
type
label
Evaluation of the efficacy of ...... heterologous PRRSV challenge.
@en
Evaluation of the efficacy of ...... and respiratory syndrome virus
@nl
prefLabel
Evaluation of the efficacy of ...... heterologous PRRSV challenge.
@en
Evaluation of the efficacy of ...... and respiratory syndrome virus
@nl
P2093
P1476
Evaluation of the efficacy of ...... heterologous PRRSV challenge.
@en
P2093
Changhoon Park
Chanhee Chae
Hwi Won Seo
Ikjae Kang
P304
P356
10.1016/J.VETMIC.2014.05.030
P577
2014-06-06T00:00:00Z